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Abstract
Background: Neurofilament proteins (Nf) are highly specific biomarkers for neuronal death and axonal degeneration. As these markers become more widely used, an inter-laboratory validation study is required to identify assay criteria for high quality performance.
Methods: The UmanDiagnostics NF-light ® enzyme-linked immunoabsorbant assays (ELISA) for the neurofilament light chain (NfL, 68 kDa) was used to test the intra-assay and inter-laboratory coefficient of variation (CV) between 35 laboratories world-wide on 15 cerebrospinal fluid (CSF) samples. Critical factors, such as sample transport and storage, analytical delays, reaction temperature and time, the laboratories' accuracy and preparation of standards were documented and used for the statistical analyses.
Results: The intra-laboratory CV averaged 3.3% and the interlaboratory CV 59%. The results from the test laboratories correlated with those from the reference laboratory (R=0.60, p<0.0001). Correcting for critical factors improved the strength of the correlation. Differences in the accuracy of standard preparation was identified as the most critical factor. Correcting for the error introduced by variation in the protein standards improved the correlation to R=0.98, p<0.0001 with an averaged inter-laboratory CV of 14%. The corrected overall inter-rater agreement was subtantial (0.6) according to Fleiss' multirater kappa and Gwet's AC1 statistics.
Conclusion: This multi-center validation study identified the lack of preparation of accurate and consistent protein standards as the main reason for a poor inter-laboratory CV. This issue is also relevant to other protein biomarkers based on this type of assay and will need to be solved in order to achieve an acceptable level of analytical accuracy. The raw data of this study is available online.
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Introduction
Protein biomarkers are relevant for diagnostics and prognosis and they are increasingly used as inclusion criteria and as a secondary outcome measure for treatment trials. With the availability of high-throughput proteomic methods large numbers of potential protein biomarkers have been discovered. However, surprisingly few withstand the test of time and bridge the bench to bedside gap. Two examples within the field of neurodegenerative diseases are the tau and amyloid-beta 1−42 proteins. Both proteins were found to be key components in the pathology of Alzheimer's disease. Several assays were developed, of which the enzyme-linked immunoabsorbant assays (ELISA) were employed routinely. Evidence emerged that cerebrospinal fluid (CSF) tau and amyloid-beta 1−42 levels could be good diagnostic tests for Alzheimer's disease [1, 2] and new diagnostic criteria including CSF tau and amyloid-beta 1−42 levels were proposed [3] . Disappointingly, repeated validation studies of CSF tau and amyloid-beta 1−42 levels demonstrated an unacceptable inter-laboratory coefficient of variation (CV) of up to 53% [4, 5, 6] . The factors influencing the CV remain largely unknown.
The present study was designed to measure the quantitative influence of a number of controllable parameters in a multicenter study involving 35 laboratories worldwide. The rationale was to control for parameters inherent to shipment and handling of test material and related to different laboratory procedures in order to optimize the inter-laboratory CV.
The biomarker chosen for analysis was the neurofilament light protein (NfL) [7, 8] . Neurofilaments are heteropolymers composed of at least four subunit proteins: α-internexin/Nf66 and the triplet of the neurofilament light, medium (NfM) and heavy chain (NfH) [9, 10] . Neurofilament proteins are the most reliable protein biomarker validated for quantification of neurodegeneration [10, 11] . Their emerging importance for basic science, clinical trials and laboratory practice cannot be overestimated.
Materials and methods

Kits and equipment
The NF-L kits were obtained from UmanDiagnostics, Umea, Sweden. The kit is a sandwich ELISA with two highly specific NF-L monoclonal antibodies and no cross-reactivity with other known brain antigens [12, 13, 14] .
Large thermometers, allowing easy visualisation of the temperature (Table 1) , were purchased from the Lab Warehouse (TG835-15). All thermometers were calibrated in London prior to shipment.
CSF samples
Fifteen CSF samples (50 mL each sample, collected from patients who underwent extraventricular drainage for management of acute hydrocephalus) were collected in polypropylene tubes and immediately centrifuged (5000 rpm for 5 minutes). Supernatants were aliquotted and stored at -80
• C in 1.5-2.0 mL Eppendorf tubes until analysis. In agreement with the Ethic Committee and the United Kingdom Human Tissue Act, all patient details were anonymised.
Analytical procedures
The ELISA (UmanDiagnostics NF-light ® ) was performed as previously described [13] . In brief, each laboratory reconstituted each of the freezedried NfL standards (purified bovine spinal cord with a purity >98%) with 240µL of sample diluent in a 1.5 mL Eppendorf vial to give a concentration of 40 ng/mL 79 . The vial was gently mixed until the standard was completely solubilized and then left to stand at room temperature (RT) for 10 minutes. A series of eight Eppendorf vials was prepared, with the first vial containing 900 µL of sample diluent and vials 2 to 8, 600 µL of sample diluent. Each laboratory then added 300 µL of the lyophilized standard to the first vial to give a concentration of 10 µg/L. A doubling dilution using 600 µL in each step was performed and vial 8 was left only with sample diluent to give the blank reading (0 ng/mL NfL). The concentration for vials 1 to 7 is summarised in Table 3 .
The freeze-dried ELISA plates were washed with 3 x 5-minute cycles with washing solution (300 µL). Next, 100 µL of standards and samples were added in quadruplicate (= 4 measurements) and incubated for 1 hour at RT at 800 rpm agitation on a shaker. After another three 5-minute wash cycles 100µL of the biotin-labeled anti-NfL monoclonal antibody were added to each well. The plate was incubated for 45 minutes (RT, 800 rpm agitation). Following another wash cycle (3 x 5 minutes), 100 µL of streptavidin-HRP conjugate were added to each well. The plate was incubated for 30 minutes (RT, 800 rpm). A last wash cycle (3 x 5 minutes) was performed and 100 µL of 3,3',5,5'-tetramethylbenzidine (TMB) were added to each well. After incubating the plate for 15 minutes (RT) the color reaction was stopped with 50 µL of stop solution (0.18 M H 2 SO 4 ). The absorbance (optical density, OD) of each well was read at 450 nm (test) and 700 nm (blank).
All laboratories performed only one run.
Data analysis and strategy for validation
The raw data was sent to London (AP) for analysis and to Amsterdam (CT) for independent control. The concentration of the NfL samples was calculated based on each laboratory's standard curve using the closest three ODs of the quadruplicates. The results were then discussed with each laboratory. One dataset was again sent to Amsterdam (CT) for independent control. Results from samples which gave a higher OD than the highest standard were excluded as this study did not allow for extrapolation. All raw data were then subjected to statistical analysis. SAS software (version 9.2, SAS Institute, Inc., Cary, North Carolina, USA) was used for all statistical analyses and graphs. Data was presented as median and interquartile range (IQR). The coefficient of variation (CV) was calculated for each measurement as the standard-deviation divided by the mean. The result was then multiplied by 100 for expression as a percentage. Correlation analyses were performed using Pearson's R for normally distributed and Spearman's R for non-Gaussian data. Partial correlation analyses were performed on predefined variables: temperature at which the ELISA was performed, time of the colorimetric reaction, time delay between shipment and analysis of samples, accuracy of each laboratory in respect to preparation of standards and intra-assay CV. The data for each sample was ranked in order to analyse the inter-laboratory agreement. The inter-laboratory agreement was assessed using kappa statistics for multiple raters and multiple samples [15] and rated as described [16] . The Fleiss' multiple rater kappa was calculated on those samples successfully measured by each laboratory using the SAS magree macro (version 1.2). The conditional kappa for each response category as well as the overall agreement are presented. In addition, kappa coefficients were also calculated using the more robust AC1 statistics introduced by Gwet [17] using the SAS inter rater macro (version 1.0, downloaded from http://www.stataxis.com/files/sas/INTER RATER.TXT).
Results
The samples were shipped on dry ice and arrived in perfect frozen storage conditions in 34 (97%) of the laboratories (Table 1 ). In one case the samples were delayed at an airport for 2 days and arrived defrosted (laboratory #26). Samples were stored at -80
• C by 33 of the laboratories until analysis. The average delay from shipment of samples to analyses was two weeks (Table 1 ). All laboratories used yellow top (100-200 µL) pipettes for pipetting samples and standards into the ELISA plate. These pipettes were specifically calibrated prior to the experiment by 51% of laboratories. In all other cases pipettes were calibrated on a routine basis as part of normal laboratory practice. For the preparation of standards 83% of laboratories used a different set of pipettes, which were able to handle larger volumes (up to 1000 µL).
The ELISA kit worked successfully in 33/35 (94%) of the participating laboratories. In two laboratories, the ELISA did not work due to very low optical densities (OD <0.01) in one, probably reflecting a pipetting error due to mismatch of antibodies. Almost uniformly high ODs were found by another laboratory (#14), probably reflecting cross-contamination. The temperature at which the ELISA was performed averaged 25
• C ( Table 1) . The time given for the colorimetric reaction averaged 14 minutes (median 15 minutes).
In nine laboratories the standard curve went into saturation. In these cases the top standard and a samples with a high NfL concentration (samples #1, #5, #6, #9, #10, #13 and #14, Figure 1 ) had to be excluded. In this study it was not allowed to extrapolate and therefore we were unable to calculate the concentration of a sample which fell outside the range of the standard curve. For this reason the NfL concentration could not be calculated from the optical density of 203/801 (26.5%) of all samples ( Table  2 ). The failure rate was highest for sample #5 (33/2, 94.3%). In contrast, the NfL concentration could be calculated from the results of all laboratories for sample #4 (35/35, 100%, Figure 1) . Table 2 summarises the success rate for determining the OD for each sample and the failure rate for calculating the absolute concentration. The percentage agreement for the ranking of samples was higher if the ranking was based on OD instead of protein concentration for 6 samples (#3, #7, #8, #10, #11, #12). The agreement between laboratories for individual samples ranged from fair (sample #2) to almost perfect (sample #4, Table 2 ). The overall agreement was substantial [16] using either Fleiss' multi-rater kappa (overall kappa 0.602, p<0.0001) or Gwet's AC1 statistics (overall conditional AC1 0.595, standard error 0.081, p<0.0001; unconditional AC1 0.595, standard error 0.084, p<0.0001.).
The overal ranking of the absolute protein concentration was identical to what was found for the OD (Table 2) . But only for one sample (#4) a result was obtained from all laboratories, preventing calculation of the inter-laboratory agreement using kappa statistics.
Intra-laboratory assay CV
The average intra-laboratory assay CV was 3.3% (median 2.7%). The breakdown for each standard and sample is summarised in Figure 2 . The intra-assay CV was best for high concentrations of NfL (standard 1: 10,000 ng/mL) and worst for low concentrations of NfL (standard 8: 0 ng/mL).
Inter-laboratory assay CV
The concentration of NfL was calculated based on each laboratory's standard curve. Figure 1 shows that there was a large discrepancy in the reported values between the laboratories. This translated to an average inter-laboratory assay CV of 59% (median 47%, Figure 3 ).
Validation parameters
This validation study was designed to assess the influence of quantifiable parameters on the inter-laboratory assay CV. The values of all laboratories were compared to those from the reference laboratory (London). Using all CSF samples, there was a weak correlation of the absolute NfL concentration of R=0.60 (p<0.0001).
Temperature The partial correlation analysis demonstrated the influence of the temperature at which the assay was performed with R decreasing to 0.58 (p<0.0001).
Time Also the time of color development had little influence on the results. Correcting for this variable in the partial correlation analysis, R increased marginally to 0.62 (p<0.0001).
Delay in analysis
The time delay between sending out the samples and analysis had no effect on the results (R=0.60, p<0.0001).
Laboratory accuracy as estimated by the intra-assay CV
The intraassay CV (accuracy of each laboratory) had no effect (R=0.60, p<0.0001).
Preparation of standards
The greatest influence on inter-laboratory validation was found to be variation in the concentration of the standards used by each laboratory to calculate the CSF NfL concentration of the samples. This is illustrated by two laboratories which analyzed the samples only two days apart at almost equal temperature (26 • C and 27
• C, Table 3 ). The two standard curves are not parallel and contain different concentrations of NfL. Surprisingly the optical densities for the CSF samples are almost identical (0-2% difference, Table 3 ). However, the reported concentration of CSF NfL differed considerably: 43-53% (Table 3) .
It is possible that a non-systematic error was introduced because 84% of the laboratories used different pipettes to prepare the standards and pipette the samples (Table 1) . In order to analyse the potential error introduced by differences in the concentration of the NfL standard, the CSF samples were normalized separately to the highest optical density for each laboratory (a one point callibration to a top value of 1). Comparing these normalised ODs, the correlation of the results improved to R=0.72 (p<0.0001). Figure 1 shows that not all laboratories measured the highest value for the same sample and the inter-laboratory rater agreement was not perfect for all samples (Table 2) . In order to standardise we selected one sample in which the protein concentration was available from most of the participating laboratories. In addition, this sample had a sufficient high protein concentration to allow for normalisation of the remaining samples. We did therefore chose to normalise for sample 7 (82% success rate for protein concentration, Table 2 ). Sample 7 had an average NfL concentration higher then in six other samples (#2, #3, #4, #8, #11, #12) with sufficient success rates to allow for a correlation analysis.Standardizing the normalization procedure to CSF sample 7 further improved the correlation to R=0.98 (p<0.0001, Figure 4 ).
Optimised inter-laboratory assay CV
Optimising the results to the largest effect found (standardisation to CSF sample 7), due to a non-systematic error in preparation of protein standards, reduced the inter-laboratory assay CV to an average of 14%. Again, a better CV was found for CSF samples with a high NfL protein concentration ( Figure 5 ).
Discussion
This validation study identified parameters influencing the inter-laboratory CV. In descending importance these were the preparation of the standard curve, time of the colorimetric reaction, delay between shipment and sample analysis, intra-laboratory CV, and temperature during the experiment. The importance of identifying these factors is highlighted by the strength of the correlation between the results from the test and reference laboratories. For uncontrolled conditions there was only a weak correlation with R=0.60 with an inter-laboratory CV of 64.8%. Under controlled conditions this was improved to a correlation of R=0.98 with an inter-laboratory CV of 14%. Under optimal conditions an inter-laboratory CV of less than 15% should be achievable.
The most important finding of this study is the influence of the preparation of the standards. Controlling for all other parameters, this can account for a two-fold difference in reported values. This variation is in part explained by limited accuracy of the pipettes. Only half of the laboratories calibrated their pipettes prior to the experiment. The other half calibrated their pipettes on a regular basis, which is generally regarded as good laboratory practice. A limitation of our study design is that this information was self-reported and could therefore be a source of unaccounted variation.
One peculiarity of NfL is that it can self-assemble [18, 19, 20, 21] . Thus the formation of aggregates is a possibility. Aggregates can be dissolved either with time or using sonication. A difference in the solubilisation of the lyophilized NfL reference probably accounts for a large part of discrepancies between laboratories. We suspect that differences between laboratories in the preparation of the standards is also the likely cause of the unacceptable high inter-laboratory CV in other studies [4, 5, 6] . At present this key factor is not controlled for by any of the available ELISA kits for protein biomarkers. It is important to note that the inter-rater reliability is typically measured when all raters (e.g. laboratories) operate under similar conditions. Therefore the identification of a new extragenous factor has two implications. Firstly, the statistical strength of the kappa coefficient is limited. Secondly, a future controlled experiment should be conducted to evaluate the effect of standard preparation on the agreement coefficient.
All enzymes work within a range of temperature. The enzyme used in this experiment was horseradish peroxidase (HRP). The colorimetric reaction depends on the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) and is optimal around 25 • C at pH 7.0. All experiments were performed under ideal thermal conditions and correcting for temperature did not improve the results.
The enzyme activity is calculated as moles of substrate converted per time unit. Because the time kinetics for HRP are not completely linear, variation in reaction time can influence the outcome of the experiment, particularly if the reaction reaches saturation. In this study saturation was reached for a number of samples. As our partial correlation analysis shows correcting for time did only have a very small effect on the data.
The delay between shipment of samples and analysis is important for protein biomarkers, which have a limited stability. NfL has been found to be stable at -80
• C 10 years after sampling [22] . Consistent with this data a delay in time from shipment to analysis was not statistically relevant.
There are substantial limitations to this study. Firstly, it was not possible to control for all extragenous factors. We have summarised all extragenous factors collected in form of a table. Secondly, the effect of the now identified relevance of standard prepartion has not been tested prospectively in a controlled experiment. We intend to address this issue in a future study. Thirdly, a number of observations have been self-reported (e.g. callibaration of pipettes). Because the participating laboratories are located in different countries and the limited experimental time, it will remain challenging to collect this information by one single observer. Fourth, to keep this manuscript focused and transparent limited use of statistical analyses was considered necessary. The raw data of our study has therefore been made available online. We are keen to hear about alternative statistical approaches to this complex issue, particularly in dealing with missing ratings which will remain a problem for this type of reliability studies. Many of the present statistical analyses were correlative. It needs to be borne in mind that a statistical correlation does not proof causality.
This large validation study on an ELISA for a protein biomarker demonstrated that the experience and accuracy (intra-assay CV) of each laboratory had only a minor influence on the outcome. This is reassuring, meaning that any laboratory should be in the position to use the ELISA, but will need to establish in-house reference ranges. In a post-hoc analysis the correlation analysis on the absolute concentration of CSF NfL levels between two laboratories experienced in the development of this type of ELISA (London and Götheborg), yielded an R of 0.99 (p<0.0001). Our conclusion from this result is that at present any treatment trial including NfL as a protein biomarker may benefit from batch analyses in one laboratory to ensure the highest degree of accuracy. The low intra-laboratory CV is encouraging in this respect. Alternatively, the use of an internal laboratory quality control (such as sample 7 in this study), is strongly recommended. This study is consistent with previous data showing that hu-man factors are an important factor adding to inaccuracy [23] . Our results therefore highlight the importance of a careful adherence to the analytical procedure. The routine application of this ELISA will require carefull training of staff including calibration procedures in order to minimise the intra-laboratory inter-assay CV.
In summary this validation study on an ELISA for the quantification of NfL from human CSF revealed difficulties, due to the preparation of accurate and consistent standards. Even though an unacceptable poor inter-laboratory assay CV is known also for other proteins, such as tau and amyloid-beta 1−42 [4, 5, 6] , this is not yet controlled for. Under optimal conditions an inter-laboratory CV of 14% should be achievable for this NfL ELISA. 
